Treatment of opsoclonus-myoclonus with high-dose intravenous immunoglobulin

Sex-specific efficacy and safety outcomes in patients with resectable stage III non-small-cell lung cancer (NSCLC) undergoing neoadjuvant therapies: a pooled analysis of the SAKK trials 16/96, 16/00, 16/01, 16/08 and 16/14.

ESMO open·2025

Neoadjuvant treatment does not influence PD-L1 expression in stage III non-small-cell lung cancer: a retrospective analysis of tumor samples from the trials SAKK 16/96, 16/00, 16/01, and 16/14.

ESMO open·2023

Long-term benefit of lurbinectedin as palliative chemotherapy in progressive malignant pleural mesothelioma (MPM): final efficacy and translational data of the SAKK 17/16 study.

ESMO open·2022

Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trials.

ESMO open·2022

A randomised phase II study of osimertinib and bevacizumab versus osimertinib alone as second-line targeted treatment in advanced NSCLC with confirmed EGFR and acquired T790M mutations: the European Thoracic Oncology Platform (ETOP 10-16) BOOSTER trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2021

Second-line therapy improves overall survival in primary refractory non-small cell lung cancer (NSCLC) patients.

ESMO open·2021

Medium-Term Cognitive Outcome in Patients With CNS Lymphomas Treated With Chimeric Antigen Receptor T-Cell Therapy.

Neurology·2026

Association of Skin Denervation With Brain Atrophy and Cognitive Impairment in Patients With Parkinson Disease.

Neurology·2026

The Mechanical Penumbra in Intracerebral Hemorrhage.

Neurology·2026

Trends in Withdrawal of Life-Sustaining Treatment in Patients With Traumatic Brain Injury, 2013-2023.

Neurology·2026

Traumatic Spinal Cord Injury Mortality in the United States, 1999-2024: A Population-Based Analysis of Temporal and Demographic Trends.

Neurology·2026

Clinical Factors Associated With Discordant Plasma P-Tau217 and Established Alzheimer Disease Biomarkers.

Neurology·2026

Outcomes of Long-Term Absorbable Mesh Use for Ventral Hernia Repair in Immunosuppressed Patients.

World journal of surgery·2026

Simultaneous Quantification of Vedolizumab, Ustekinumab, and Infliximab in Human Serum by LC-MS/MS: Application to Therapeutic Drug Monitoring in Inflammatory Bowel Disease.

Drug design, development and therapy·2026

Bispecific antibodies that engage pIgR enrich in mucosa in cynomolgus monkeys.

mAbs·2026

Infection Prevention and Management in Patients With Multiple Myeloma Treated With Bispecific Antibodies: A Case-Based Approach for Routine Clinical Practice.

Clinical lymphoma, myeloma & leukemia·2026

Anti-CD20 monoclonal antibodies in membranous nephropathy.

Nefrologia·2026

Related Experiment Videos

Treatment of opsoclonus-myoclonus with high-dose intravenous immunoglobulin

Related Concept Videos

Sex-specific efficacy and safety outcomes in patients with resectable stage III non-small-cell lung cancer (NSCLC) undergoing neoadjuvant therapies: a pooled analysis of the SAKK trials 16/96, 16/00, 16/01, 16/08 and 16/14.

Neoadjuvant treatment does not influence PD-L1 expression in stage III non-small-cell lung cancer: a retrospective analysis of tumor samples from the trials SAKK 16/96, 16/00, 16/01, and 16/14.

Long-term benefit of lurbinectedin as palliative chemotherapy in progressive malignant pleural mesothelioma (MPM): final efficacy and translational data of the SAKK 17/16 study.

Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trials.

A randomised phase II study of osimertinib and bevacizumab versus osimertinib alone as second-line targeted treatment in advanced NSCLC with confirmed EGFR and acquired T790M mutations: the European Thoracic Oncology Platform (ETOP 10-16) BOOSTER trial.

Second-line therapy improves overall survival in primary refractory non-small cell lung cancer (NSCLC) patients.

Medium-Term Cognitive Outcome in Patients With CNS Lymphomas Treated With Chimeric Antigen Receptor T-Cell Therapy.

Association of Skin Denervation With Brain Atrophy and Cognitive Impairment in Patients With Parkinson Disease.

The Mechanical Penumbra in Intracerebral Hemorrhage.

Trends in Withdrawal of Life-Sustaining Treatment in Patients With Traumatic Brain Injury, 2013-2023.

Traumatic Spinal Cord Injury Mortality in the United States, 1999-2024: A Population-Based Analysis of Temporal and Demographic Trends.

Clinical Factors Associated With Discordant Plasma P-Tau217 and Established Alzheimer Disease Biomarkers.

Outcomes of Long-Term Absorbable Mesh Use for Ventral Hernia Repair in Immunosuppressed Patients.

Simultaneous Quantification of Vedolizumab, Ustekinumab, and Infliximab in Human Serum by LC-MS/MS: Application to Therapeutic Drug Monitoring in Inflammatory Bowel Disease.

Bispecific antibodies that engage pIgR enrich in mucosa in cynomolgus monkeys.

Infection Prevention and Management in Patients With Multiple Myeloma Treated With Bispecific Antibodies: A Case-Based Approach for Routine Clinical Practice.

Anti-CD20 monoclonal antibodies in membranous nephropathy.

Related Experiment Videos

Treatment of opsoclonus-myoclonus with high-dose intravenous immunoglobulin

Related Concept Videos

Related Articles